A Member of the Cancer Information Network
Cancer Information by State:
  arrow Patient Home   arrow Professional Home   arrow Newsletters   arrow Feedback Survey  
Main Menu
Quick Links
Information by Disease
Cancer News
Conference Coverage
Oncology Stocks
AZN$44.14-0.27 (-0.61%)
NVS$54.5112-0.1288 (-0.24%)
SNY$38.13-0.05 (-0.13%)
GSK$37.592-0.128 (-0.34%)
click here
Breast Cancer Information Center
Folder Conference Coverage

 
People Current Topics

Molecularly Targeted Therapies for Breast Cancer

Monoclonal Antibody Therapy for Breast Cancer

Medical Genomics: Implications for Clinical Oncology

 
News Latest Breast Cancer News

Avastin® Not Contraindicated in Patients with CNS Metastases (3/8/2010)
Researchers from France have reported that patients with central nervous system (CNS) metastases have similar rates of whether or not they receive Avastin® (bevacizumab). The details of this study appeared in the January 2010 issue of Clinical Cancer Research.

Bisphosphonates for Osteoporosis Treatment May Decrease Risk of Breast Cancer (3/4/2010)
Researchers from the University of Wisconsin have reported that the use of bisphosphonates for osteoporosis treatment may reduce the risk of developing breast cancer. The details of this study were published in the March 1, 2010 issue of the British Journal of Cancer.

Oncotype DX® Recurrence Scores Similar in United States and Asia-Pacific (3/3/2010)
Researchers have reported that the results of the Oncotype DX® breast cancer test are similar among patients in the United States and Asia-Pacific, suggesting that the test may help guide breast cancer treatment decisions in both regions. These results were presented at the 6th Annual Conference of the Organisation for Oncology and Translational Research (OOTR) in Japan in February 2010.

Regular Aspirin Use Decreases Distant Recurrences and Decreases Breast Cancer Deaths in Women with Early-stage Breast Cancer (2/26/2010)
Researchers affiliated with the Nurses’ Health Study have reported that women with early-stage breast cancer living at least one year after diagnosis have a decreased risk of distant relapse and lower mortality if they are regular users of aspirin.

Decline in Breast Cancer Incidence Limited to White Non-Hispanic Women in High-income Counties (2/23/2010)
Researchers from Harvard Medical School have reported that the recent decline in breast cancer incidence was restricted to White non-Hispanic women in high-income counties and probably reflects discontinuation of hormone therapy. The details of this study appeared in an early online publication in the American Journal of Public Health on February 10, 2010.

More Breast Cancer News »

Breast Cancer Drug Pipeline

What's in the pipeline for Breast Cancer.
Newsletters

Register in our member center today to receive a monthly newsletter with clinical news, conference coverage, and current topic updates.
 
Information by Cancer Type

 Supportive Care Centers

 Physician Resources




© 1998-2010 CancerConsultants.com  All Rights Reserved.